By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market Thursday that its second-quarter revenues declined 2 percent year over year, as blood screening revenues dropped sharply.

The San Diego-based molecular diagnostics firm brought in total revenues of $135.9 million for the three-month period ended June 30, compared with revenues of $138.6 million for the second quarter of 2010. Product sales were virtually flat at $132.9 million versus $132.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.